Published Online First: 12 July 2006. doi:10.1136/jcp.2006.038752
Journal of Clinical Pathology 2007;60:167-172
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL
Joost C van Galen1,*,
Jettie J F Muris1,*,
Joost J Oudejans1,
Wim Vos1,
Cindy P E Giroth1,
Gert J Ossenkoppele2,
Arie P Otte3,
Frank M Raaphorst1,4,
Chris J L M Meijer1
1 Departments of Pathology, VU Medical Center, Amsterdam, The Netherlands
2 Departments of Haematology, VU Medical Center, Amsterdam, The Netherlands
3 Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands
4 Crucell Holland BV,Leiden, The Netherlands
Correspondence to:
Dr J J Oudejans
Department of Clinical Pathology, VU Medical Center, De Boelelaan 1117, 1007 MB Amsterdam, The Netherlands; jj.oudejans{at}vumc.nl
Background: : Clinical outcome in patients with diffuse large B cell lymphomas (DLBCL) is highly variable and poorly predictable. Microarray studies showed that patients with DLBCL with a germinal centre B cell-like (GCB) phenotype have a better prognosis than those with an activated B cell-like (ABC) phenotype. The BMI1 proto-oncogene was identified as one of the genes present in the signature of the ABC type of DLBCL, associated with a poor prognosis.
Objectives: : (1) To investigate, in primary nodal DLBCL, the expression of BMI1 and its association with clinical outcome and DLBCL signature; (2) to look for an association between BMI1 expression and the expression of its putative downstream targets p14ARF and p16INK4a.
Results: : BMI1 expression was found to be associated with poor clinical outcome, but not clearly with an ABC-like phenotype of DLBCL. Expression of BMI1 was frequently, but not always, related to low levels of expression of p14ARF and p16INK4a.
Conclusion: : Expression of BMI1 is associated with an unfavourable clinical outcome of primary nodal DLBCL.
Abbreviations: ABC, activated B cell; DLBCL, diffuse large B cell lymphomas; GCB, germinal centre B cells
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.